Progress in New Agents to Treat Breast Cancer
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".
Deadline for manuscript submissions: 20 November 2025 | Viewed by 1799
Special Issue Editor
Interests: breast cancer; global health disparities; tumor microenvironment; epigenomics; chemoresistance; cancer stem cells; phytomedicine; experimental therapeutics; single cell genomics
Special Issue Information
Dear Colleagues,
Breast cancer is the most common cancer among women worldwide; however, breast cancer incidence varies. Overall, breast cancer survival rates have been increasing, in part due to breakthrough therapeutics that target sites within tumors that cells rely on for growth. Chemotherapeutic agents continue to demonstrate efficacy, particularly when combined with targeted therapy agents. However, chemoresistance onset and toxicities limit the utility of chemotherapeutic agents. Resistance can occur even among patients who use targeted therapy. Furthermore, disparities in breast cancer survival exist based on patient ancestry. This Special Issue explores research progress of new drugs designed to treat breast cancer more effectively.
We invite contributions that explore these dimensions of new drugs for breast cancer treatments. Through this Special Issue, we aim to foster a comprehensive dialog that propels the breast cancer field forward.
Dr. Eileen Brantley
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- breast cancer
- chemotherapeutic agents
- DNA-alkylating drugs
- anthracyclines
- antimetabolites
- taxanes
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
